Product Information
HYDROCORT-PRAMOXINE 2.5-1% CRM is a generic product labeled by TruPharma LLC, priced at $1.5883 per GM under NDC 52817081701. Its NADAC has been published 237 times since Mar 23, 2022.
Strength
2.5; 1 g/100g; g/100g
Manufacturer
TruPharma LLCNDC
52817081701
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
11/19/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORT-PRAMOXINE 2.5-1% CRM has been published 237 times since Mar 23, 2022, and over the history we have for it it has declined 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5883 per GM |
|---|---|
| All-time high | $2.0676 (May 11, 2022) |
| All-time low | $1.2544 (Jul 17, 2024) |
| 52-week high | $1.8580 |
| 52-week low | $1.5883 |
| Median price | $1.6950 |
| Average price | $1.6921 |
| Largest weekly change | +35.8% (Sep 20, 2023) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocortisone Acetate, Pramoxine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TruPharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocortisone Acetate, Pramoxine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORT-PRAMOXINE 2.5-1% CRM?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORT-PRAMOXINE 2.5-1% CRM, manufactured by TruPharma LLC, is $1.5883 per GM (NDC 52817081701), effective Sep 30, 2026.
How has the price of HYDROCORT-PRAMOXINE 2.5-1% CRM changed over time?
Over the history we have for it, the NADAC for HYDROCORT-PRAMOXINE 2.5-1% CRM has declined 23.2%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for HYDROCORT-PRAMOXINE 2.5-1% CRM?
Since Mar 23, 2022, the NADAC for HYDROCORT-PRAMOXINE 2.5-1% CRM has ranged from a low of $1.2544 (Jul 17, 2024) to a high of $2.0676 (May 11, 2022), with a median of $1.6950 per GM.
Are there cheaper alternatives to HYDROCORT-PRAMOXINE 2.5-1% CRM?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCORT-PRAMOXINE 2.5-1% CRM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCORT-PRAMOXINE 2.5-1% CRM?
HYDROCORT-PRAMOXINE 2.5-1% CRM (NDC 52817081701) is labeled by TruPharma LLC, and CMS classifies it as a generic product.